4//SEC Filing
Prokocimer Philippe 4
Accession 0001181431-13-016012
CIK 0001356857other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:47 PM ET
Size
5.1 KB
Accession
0001181431-13-016012
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2013-03-07+150,000→ 150,000 totalExercise: $6.13Exp: 2023-03-06→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 successive equal monthly installments over the four year period beginning on March 7, 2013.
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeother
Related Parties
1- filerCIK 0001479790
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:47 PM ET
- Size
- 5.1 KB